Total Payments
$960.48
2024 Payments
$752.69
Companies
23
Transactions
60
Medicare Patients
858
Medicare Billing
$36,189
Payment Breakdown by Category
Food & Beverage$960.48 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $960.48 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $209.05 | 19 | $0 (2024) |
| Lilly USA, LLC | $96.71 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $80.79 | 3 | $0 (2024) |
| Novo Nordisk Inc | $78.34 | 5 | $0 (2024) |
| PFIZER INC. | $67.91 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $46.35 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $38.74 | 2 | $0 (2024) |
| Amgen Inc. | $34.69 | 2 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $34.14 | 2 | $0 (2024) |
| Corium, LLC | $31.39 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $752.69 | 49 | ABBVIE INC. ($179.52) |
| 2023 | $207.79 | 11 | AstraZeneca Pharmaceuticals LP ($53.30) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $0.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: Endocrinology | ||||||
| 08/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Neurology | ||||||
| 08/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Endocrinology | ||||||
| 08/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: VACCINE | ||||||
| 07/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: VACCINES | ||||||
| 07/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Obesity | ||||||
| 07/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Gastroenterology | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Gastroenterology | ||||||
| 06/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 364 | 420 | $31,653 | $15,361 |
| 2021 | 12 | 333 | 336 | $43,193 | $15,410 |
| 2020 | 7 | 161 | 162 | $16,345 | $5,418 |
Total Patients
858
Total Services
918
Medicare Billing
$36,189
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 110 | $17,600 | $9,118 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 55 | $6,050 | $3,195 | 52.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 20 | 20 | $1,500 | $692.40 | 46.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 54 | 61 | $865.00 | $512.40 | 59.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 30 | $1,080 | $486.60 | 45.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 22 | 24 | $720.00 | $248.40 | 34.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 12 | $360.00 | $222.00 | 61.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 22 | 26 | $650.00 | $215.54 | 33.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 12 | 12 | $600.00 | $197.52 | 32.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 30 | 31 | $620.00 | $196.54 | 31.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $1,230 | $143.54 | 11.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 11 | 13 | $312.00 | $98.93 | 31.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 11 | 11 | $66.00 | $34.21 | 51.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 69 | $17,354 | $6,115 | 35.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 41 | $7,325 | $2,284 | 31.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,978 | $1,710 | 43.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $4,188 | $1,707 | 40.8% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 20 | 20 | $2,912 | $958.96 | 32.9% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 27 | 27 | $1,431 | $953.91 | 66.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 19 | $1,925 | $883.80 | 45.9% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2021 | 25 | 25 | $1,350 | $315.79 | 23.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 29 | 29 | $1,073 | $217.56 | 20.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 43 | 43 | $559.00 | $129.00 | 23.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 18 | 18 | $666.00 | $68.34 | 10.3% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 12 | 12 | $432.00 | $66.60 | 15.4% |
About Lawrence Berndt, P.A.-C
Lawrence Berndt, P.A.-C is a Medical healthcare provider based in Midlothian, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1477678530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lawrence Berndt, P.A.-C has received a total of $960.48 in payments from pharmaceutical and medical device companies, with $752.69 received in 2024. These payments were reported across 60 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($960.48).
As a Medicare-enrolled provider, Berndt has provided services to 858 Medicare beneficiaries, totaling 918 services with total Medicare billing of $36,189. Data is available for 3 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Midlothian, VA
- Active Since 03/20/2007
- Last Updated 02/11/2021
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1477678530
Products in Payments
- QULIPTA (Drug) $176.46
- FARXIGA (Drug) $80.79
- JARDIANCE (Drug) $47.91
- Rybelsus (Drug) $47.54
- PREVNAR 20 (Biological) $40.80
- EVENITY (Biological) $34.69
- MOUNJARO (Drug) $34.17
- XIFAXAN (Drug) $34.14
- TRELEGY ELLIPTA (Drug) $33.38
- UBRELVY (Drug) $32.59
- Azstarys (Drug) $31.39
- Tymlos (Drug) $30.37
- ELIQUIS (Drug) $27.11
- AVEED (Biological) $22.56
- LEQVIO (Drug) $21.90
- Leqembi (Drug) $21.40
- Heplisav-B (Drug) $19.20
- (CK6) Holter (Device) $18.18
- IBSRELA (Drug) $17.87
- Dexcom G6 Transmitter (Medical Supply) $17.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Midlothian
Nguyet Nguyen, Physician Assistant, PHYSICIAN ASSISTANT
Medical — Payments: $11,754
Medical $11,754
Joshua Harris, Pa, PA
Medical — Payments: $6,580
Medical $6,580
Dustin Bogan, Pa-C, PA-C
Medical — Payments: $2,429
Medical $2,429
Sarah Trezza, P.a, P.A
Medical — Payments: $1,915
Medical $1,915
Mrs. Mamta Patel, Pa-C, PA-C
Medical — Payments: $1,775
Medical $1,775
Mr. Wesley Bull, Pa-C, PA-C
Medical — Payments: $1,536
Medical $1,536